Evidence map›Paper›PMID 20072156›Full record

ArticleLeukemia2010

The downregulation of onzin expression by PKCepsilon-ERK2 signaling and its potential role in AML cell differentiation.

S-F Wu, Y Huang, J-K Hou, T-T Yuan, C-X Zhou, J Zhang, G-Q Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Multifaced roles of PLAC8 in cancer.Biomarker research · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

S-F WuInstitute of Health Science, Shanghai Institutes for Biological Sciences of Chinese Academy of Sciences-Shanghai Jiaotong University School of Medicine (SJTU-SM), Shanghai, China.
Y Huang
J-K Hou
T-T Yuan
C-X Zhou
J Zhang
G-Q Chen
Shanghai Institutes for Biological Sciences · CNDeleted Institution

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Onzin is a small, novel, and highly conserved protein with unique structure and tissue-restricted expression. The regulation of its expression and biological roles remain greatly elusive. Here, we provide the first demonstration that onzin expression is significantly downregulated during differentiation induction of acute myeloid leukemic (AML) cell lines and primary cells by all-trans retinoic acid (ATRA) and especially by phorbol 12-myristate 13-acetate (PMA). Applying chemical inhibitions, RNA interferences, and transfected expressions of dominant negative mutants or constitutive catalytic forms of the related kinases, we show that protein kinase C-epsilon (PKCepsilon)-extracellular signal-regulated protein kinase 2 (ERK2) signaling axis is required for PMA-induced downregulation of onzin expression. The ectopic expression of onzin partially inhibits PMA-induced monocytic differentiation of AML cells, whereas suppression of onzin by specific short hairpin RNAs enhances PMA-induced differentiation to a degree. Furthermore, onzin partially inhibits the transcriptional activity of hematopoiesis-related important transcription factor PU.1 via their interaction. Taken together, our results show that PMA downregulates onzin expression through PKCepsilon-ERK2 signaling pathway, which favors monocytic differentiation of leukemic cells.

Indexed as

Cell DifferentiationCell Line, TumorDown-RegulationHumansLeukemia, Myeloid, AcuteMitogen-Activated Protein Kinase 1Oncogene ProteinsProtein Kinase C-epsilonProteinsProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Signal TransductionTetradecanoylphorbol AcetateTrans-ActivatorsTretinoinMitogen-Activated Protein Kinase 1Oncogene ProteinsPLAC8 protein, humanProtein Kinase C-epsilonProteinsProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Tetradecanoylphorbol AcetateTrans-ActivatorsTretinoin

Identifiers

PMID20072156
OpenAlexW2135740900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.